A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for...
Patients with hepatitis C virus (HCV) have a higher prevalence of comorbidities and multimorbidity compared with the general population, according to a study published in BMC Infectious Diseases. In this retrospective...
Researchers have been trying for decades to develop a vaccine against the globally endemic hepatitis C virus (HCV). Now scientists at The Scripps Research Institute (TSRI) have discovered one reason why success has so...
An international team of researchers has shed light on the potential impact of new drugs for hepatitis C virus (HCV). HCV is an important cause of liver cancer and is transmitted through blood to blood contact. People...
A combined vaccination against Hepatitis C virus (HCV) and HIV moved a step closer, with the results of a study* presented at The International Liver Congress™ 2016 in Barcelona, Spain. An estimated 2.3 million people...